280 related articles for article (PubMed ID: 11866476)
1. Reduction of toxic metabolite formation of acetaminophen.
Hazai E; Vereczkey L; Monostory K
Biochem Biophys Res Commun; 2002 Mar; 291(4):1089-94. PubMed ID: 11866476
[TBL] [Abstract][Full Text] [Related]
2. Acetaminophen bioactivation by human cytochrome P450 enzymes and animal microsomes.
Laine JE; Auriola S; Pasanen M; Juvonen RO
Xenobiotica; 2009 Jan; 39(1):11-21. PubMed ID: 19219744
[TBL] [Abstract][Full Text] [Related]
3. Activation of acetaminophen-reactive metabolite formation by methylxanthines and known cytochrome P-450 activators.
Lee CA; Thummel KE; Kalhorn TF; Nelson SD; Slattery JT
Drug Metab Dispos; 1991; 19(5):966-71. PubMed ID: 1686244
[TBL] [Abstract][Full Text] [Related]
4. In-source formation of N-acetyl-p-benzoquinone imine (NAPQI), the putatively toxic acetaminophen (paracetamol) metabolite, after derivatization with pentafluorobenzyl bromide and GC-ECNICI-MS analysis.
Tsikas D; Trettin A; Zörner AA; Gutzki FM
J Chromatogr B Analyt Technol Biomed Life Sci; 2011 May; 879(17-18):1476-84. PubMed ID: 21353649
[TBL] [Abstract][Full Text] [Related]
5. Involvement of human cytochrome P450 2D6 in the bioactivation of acetaminophen.
Dong H; Haining RL; Thummel KE; Rettie AE; Nelson SD
Drug Metab Dispos; 2000 Dec; 28(12):1397-400. PubMed ID: 11095574
[TBL] [Abstract][Full Text] [Related]
6. Contribution of CYP2E1 and CYP3A to acetaminophen reactive metabolite formation.
Manyike PT; Kharasch ED; Kalhorn TF; Slattery JT
Clin Pharmacol Ther; 2000 Mar; 67(3):275-82. PubMed ID: 10741631
[TBL] [Abstract][Full Text] [Related]
7. Prevention of acetaminophen (APAP)-induced hepatotoxicity by leflunomide via inhibition of APAP biotransformation to N-acetyl-p-benzoquinone imine.
Tan SC; New LS; Chan EC
Toxicol Lett; 2008 Aug; 180(3):174-81. PubMed ID: 18588957
[TBL] [Abstract][Full Text] [Related]
8. Protective effect of diallyl sulfone against acetaminophen-induced hepatotoxicity in mice.
Lin MC; Wang EJ; Patten C; Lee MJ; Xiao F; Reuhl KR; Yang CS
J Biochem Toxicol; 1996; 11(1):11-20. PubMed ID: 8806047
[TBL] [Abstract][Full Text] [Related]
9. Protection against acetaminophen toxicity in CYP1A2 and CYP2E1 double-null mice.
Zaher H; Buters JT; Ward JM; Bruno MK; Lucas AM; Stern ST; Cohen SD; Gonzalez FJ
Toxicol Appl Pharmacol; 1998 Sep; 152(1):193-9. PubMed ID: 9772215
[TBL] [Abstract][Full Text] [Related]
10. Role of NAD(P)H:quinone oxidoreductase 1 in clofibrate-mediated hepatoprotection from acetaminophen.
Moffit JS; Aleksunes LM; Kardas MJ; Slitt AL; Klaassen CD; Manautou JE
Toxicology; 2007 Feb; 230(2-3):197-206. PubMed ID: 17188792
[TBL] [Abstract][Full Text] [Related]
11. Effects of caffeine and theophylline on acetaminophen pharmacokinetics: P450 inhibition and activation.
Lee CA; Lillibridge JH; Nelson SD; Slattery JT
J Pharmacol Exp Ther; 1996 Apr; 277(1):287-91. PubMed ID: 8613932
[TBL] [Abstract][Full Text] [Related]
12. Cataract formation by a semiquinone metabolite of acetaminophen in mice: possible involvement of Ca(2+)and calpain activation.
Qian W; Shichi H
Exp Eye Res; 2000 Dec; 71(6):567-74. PubMed ID: 11095908
[TBL] [Abstract][Full Text] [Related]
13. Oxidation of acetaminophen to N-acetyl-p-aminobenzoquinone imine by human CYP3A4.
Thummel KE; Lee CA; Kunze KL; Nelson SD; Slattery JT
Biochem Pharmacol; 1993 Apr; 45(8):1563-9. PubMed ID: 8387297
[TBL] [Abstract][Full Text] [Related]
14. Mechanism of cytochrome P450 activation by caffeine and 7,8-benzoflavone in rat liver microsomes.
Lee CA; Manyike PT; Thummel KE; Nelson SD; Slattery JT
Drug Metab Dispos; 1997 Oct; 25(10):1150-6. PubMed ID: 9321518
[TBL] [Abstract][Full Text] [Related]
15. Trapping of NAPQI, the intermediate toxic paracetamol metabolite, by aqueous sulfide (S²⁻) and analysis by GC-MS/MS.
Trettin A; Batkai S; Thum T; Jordan J; Tsikas D
J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Jul; 963():99-105. PubMed ID: 24950097
[TBL] [Abstract][Full Text] [Related]
16. Ethanol and production of the hepatotoxic metabolite of acetaminophen in healthy adults.
Thummel KE; Slattery JT; Ro H; Chien JY; Nelson SD; Lown KE; Watkins PB
Clin Pharmacol Ther; 2000 Jun; 67(6):591-9. PubMed ID: 10872641
[TBL] [Abstract][Full Text] [Related]
17. Combination of electrochemistry and nuclear magnetic resonance spectroscopy for metabolism studies.
Simon H; Melles D; Jacquoilleot S; Sanderson P; Zazzeroni R; Karst U
Anal Chem; 2012 Oct; 84(20):8777-82. PubMed ID: 22971210
[TBL] [Abstract][Full Text] [Related]
18. Inactivation of glyceraldehyde-3-phosphate dehydrogenase by a reactive metabolite of acetaminophen and mass spectral characterization of an arylated active site peptide.
Dietze EC; Schäfer A; Omichinski JG; Nelson SD
Chem Res Toxicol; 1997 Oct; 10(10):1097-103. PubMed ID: 9348431
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms of N-acetyl-p-benzoquinone imine cytotoxicity.
Albano E; Rundgren M; Harvison PJ; Nelson SD; Moldéus P
Mol Pharmacol; 1985 Sep; 28(3):306-11. PubMed ID: 4033631
[TBL] [Abstract][Full Text] [Related]
20. The effect of omeprazole pretreatment on acetaminophen metabolism in rapid and slow metabolizers of S-mephenytoin.
Sarich T; Kalhorn T; Magee S; al-Sayegh F; Adams S; Slattery J; Goldstein J; Nelson S; Wright J
Clin Pharmacol Ther; 1997 Jul; 62(1):21-8. PubMed ID: 9246016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
